Liu, Shuozi
Zhou, Shaowei
Zhang, Weilong
Wang, Jing
Wang, Lingli
Li, Chunyuan
Chen, Yingtong
Qi, Wenxin
Yang, Ping
Jing, Hongmei
Funding for this research was provided by:
National Natural Science Foundation of China (81800195)
Key Clinical Projects of Peking University Third Hospital (BYSYZD2019026)
Beijing Xisike Clinical Oncology Research Foundation (Y-NCJH202201-0049)
the special fund of the National Clinical Key Specialty Construction Program, P. R. China (2023).
the National Clinical Key Specialty Construction Program, P. R. China
Beijing Natural Science Foundation (7232202)
Beijing Municipal Health Commission, Capital's Funds for Health Improvement and Research (2024-2-4096)
Article History
Received: 11 September 2024
Accepted: 4 December 2025
First Online: 21 January 2026
Declarations
:
: This project was approved by the Institutional Review Board of Peking University Third Hospital.
: The authors declare no competing interests.